Current location - Trademark Inquiry Complete Network - Tian Tian Fund - Why can Russia lead the research and development of the new coronavirus vaccine?
Why can Russia lead the research and development of the new coronavirus vaccine?

Since 2019, the outbreak of the new coronavirus has caused panic among many people.

The virus is spreading around the world, and since 2019, medical personnel around the world have been researching and producing vaccines that can resist COVID-19.

On August 11, Russian President Putin announced the registration of Russia’s first vaccine.

Russia's health minister said that this vaccine can give people immunity for two years.

Vaccinations in Russia are all paid for by the Russian state.

People from more than 20 countries have requested to apply for the vaccine, hoping that Russia can provide 1 billion vaccines.

Russia stated that the vaccine will be in circulation on the market starting from January 1, 2021.

Beyond this.

Kirill Dmitriev, president of the Russian Direct Investment Fund, said that Russia has reached an agreement with five countries to produce vaccines developed by Russia in Russia, and can produce 500 million doses of vaccines every year.

At the same time, the Russian president also said that his daughter had been the first to receive the vaccine.

It will be released and produced only after making sure that the vaccine is truly resistant.

The Russian president said at a meeting that he hopes the vaccine can enter mass production as soon as possible.

And he went through the details of his daughter's vaccinations.

I have to say that Russia is really great. After developing a vaccine, it did not hide it, but selflessly mass-produced the vaccine to the world.

On the first day after Putin's daughter was vaccinated, her body temperature was 38 degrees, and on the second day it dropped to 37 degrees.

The body temperature will rise after the second vaccination, but this is normal.

It will recover soon.

Moreover, the Russian Ministry of Health stated that it will first provide vaccines to medical staff and middle-aged and elderly people.

Moreover, the Russian Minister of Health stated that Russia hopes to start large-scale mass production of this vaccine in October this year.

All costs will be covered by the state budget.

From the outbreak in 2019 to the successful development of the vaccine in August 2020, I really have to pay tribute to these great medical staff and researchers.